Understanding Genitourinary Syndrome of Menopause
Vaginal dryness, painful sex, recurrent UTIs, and new urinary burning after menopause are part of one syndrome with one cornerstone treatment. In November 2025, the FDA removed an old black-box warning from that treatment. This guide covers what changed and what to ask your doctor for by name.
Welcome
If you have vaginal dryness, pain with sex, frequent urinary tract infections, or new burning when you pee, and you are in perimenopause, menopause, or beyond, there's a name for the pattern: Genitourinary Syndrome of Menopause, or GSM. About 5 to 7 women out of 10 develop it after menopause, and fewer than 1 in 4 ever get treatment.
GSM has a cornerstone treatment: low-dose vaginal estrogen. It works well for most women, and the safety data have been solid for two decades. The treatment carried an old FDA warning until November 2025, when the FDA took the warning off. This guide tells you what GSM is, why it happens, what to do about it, and how to ask for the right treatment by name.
How to use this guide. If you have any GSM symptoms, read Chapter 5 on vaginal estrogen. That is the most important chapter. Chapter 6 covers other treatment options. Chapter 7 is for breast cancer survivors, where the guidance has changed and the answer is now case-by-case. Chapter 10 has questions to bring to your next visit.
What is GSM?
Genitourinary Syndrome of Menopause is a named medical condition. Until 2014 it was called vulvovaginal atrophy or atrophic vaginitis, terms that left out the urinary and sexual symptoms most patients actually describe in clinic.
A syndrome with several parts
GSM is a group of changes that happen to the vagina, vulva, bladder, and urethra when your estrogen drops. The tissues in all of those places need estrogen to stay healthy. They share the same early-life origin and they all carry estrogen sensors. When estrogen falls, these tissues thin out, lose blood flow, and lose the good bacteria that lived there.
The result is a pattern of symptoms. They include vaginal dryness, vulvar irritation, painful sex, recurrent urinary tract infections, urgency, and burning when you pee. Most women with GSM have three or four of these at once.
Why the name changed
"Vulvovaginal atrophy" sounded like a small skin issue, and "atrophic vaginitis" sounded like a minor infection. Neither name covered the urinary part or the sex part. In 2014, the menopause society and the women's sexual health society renamed it Genitourinary Syndrome of Menopause to cover all four symptom areas under one diagnosis.
Who gets it
Most women after menopause. The biggest single risk factor is low estrogen. That can come from natural menopause, from having your ovaries removed, from breast cancer treatments, from medicines that shut down the ovaries, and from breastfeeding.
Why this happens to your body
GSM is biology, driven by one change: less estrogen reaching tissues that need it. Hygiene, soap choices, and how you've aged have nothing to do with it.
What estrogen was doing for you
Before menopause, estrogen kept the vagina thick, stretchy, and moist. It fed the good bacteria, called lactobacilli, that kept the vagina acidic and crowded out bad bugs. The bladder and urethra lining stayed strong. So did the labia and the opening of the vagina.
What happens when estrogen drops
- The vaginal lining gets thin and easy to tear.
- The vagina loses its acidic shield. As the pH rises, good bacteria die off and bad bugs move in.
- The labia lose some of their fullness, and the vaginal opening can narrow.
- The lining of the urethra and bladder gets thin too. That brings on burning, urgency, and recurrent UTIs.
- Natural lubrication during sex drops. Pain follows.
Causes of low estrogen
- Natural menopause. The average age in the United States is 51 to 52. Symptoms often start in late perimenopause, before periods stop for good.
- Surgical menopause. Having both ovaries removed. Estrogen drops to zero overnight, and GSM tends to come on faster and harder.
- Breast cancer drugs. Some of them lower your estrogen, and chemo can do the same. This group is called aromatase inhibitors (anastrozole, letrozole, exemestane). Tamoxifen works in a different way. It blocks the effect of estrogen.
- Drugs that quiet the ovaries. These are called gonadotropin-releasing hormone (GnRH) agonists. Doctors use them for endometriosis or fibroids.
- Breastfeeding. Temporary low estrogen during lactation can cause GSM. This is often missed because the patient is young.
Things that make it worse but do not cause it
- Smoking. Lowers estrogen further.
- Long stretches with no vaginal activity or stimulation. The muscles tighten and the tissue gets stiffer.
- Pelvic radiation. It adds scar tissue on top of low estrogen.
You did not cause this. Your body lost estrogen and the tissues that needed it are showing the effect. Soap, kegels, and how much water you drink: none of that drives it.
Symptoms and red flags
GSM has four symptom areas. Most women with GSM have some of each. Because the symptoms show up in different parts of the body, they are easy to treat as separate problems instead of one syndrome.
Vaginal symptoms
- Dryness (the most common single complaint)
- Burning or itching
- Soreness or pressure
- Thin, watery, or yellowish discharge
- Light bleeding from rubbing (with sex, an exam, exercise, or even wiping)
Vulvar symptoms
- Outside irritation, burning, or rawness
- Less full labia; the tissue may look paler
- Small splits or cracks at the opening of the vagina
Sexual symptoms
- Painful sex, most often at the entrance
- Less lubrication, even when you feel aroused
- Lower arousal and weaker orgasm
- Lower desire, often because pain has trained the body to avoid sex
- Light bleeding or spotting after sex
Urinary symptoms
- Burning when you pee, even without an infection
- Sudden urgency and frequent trips to the bathroom
- Waking at night to pee
- Recurrent urinary tract infections. If you are past menopause and getting frequent UTIs, GSM is almost always part of the picture.
You bleed after menopause and it is not from sex or an exam. You have a new lump or sore on the vulva that does not heal. Your discharge changes and has a strong smell. You see swelling on just one side. These can be signs of something other than GSM and need a closer look.
How GSM is diagnosed
GSM is a clinical diagnosis. That means your doctor makes it from your story and a careful exam. There is no blood test or scan needed.
The conversation
A primary care visit is usually short. Vaginal, sexual, and urinary symptoms can be hard to raise. Naming them yourself is often what gets GSM diagnosed.
If your doctor does not ask, you can start the talk this way: "I have some dryness, painful sex, and urinary changes since menopause. Could this be GSM?"
What your visit should include
- A history. When did your periods stop? Any breast cancer, ovaries removed, medicines that lower estrogen? Symptoms in each of the four areas? What have you tried (lubricants, moisturizers, past estrogen)?
- A pelvic exam. The doctor looks for pale, smooth vaginal tissue, labia that look less full, and an opening that has narrowed. There may also be small cracks or signs that the urethra is sore. Often a smaller speculum is used to keep the exam comfortable.
- A urine sample, if you have urinary symptoms. This rules out a current infection.
What is usually not needed
- Hormone blood tests such as follicle-stimulating hormone (FSH) and estradiol. Menopause is a clinical call. So is GSM.
- Pelvic ultrasound, unless there is bleeding to work up.
- Cystoscopy, unless there is blood in the urine or another reason.
Before your visit, jot down: which symptoms you have, how long, what you have tried, and whether sex still happens (and whether it hurts).
Vaginal estrogen: the cornerstone
Vaginal estrogen is the single most effective treatment for moderate or severe GSM. It restores the biology that menopause took away. For two decades it carried an FDA warning that did not match how the low-dose form actually works. The warning came off in November 2025.
What it is
A small dose of estrogen put right into the vagina. It comes as a cream, a tiny tablet that dissolves, or a slow-release ring. It works on the tissue where you place it. Very little gets into your bloodstream.
What it does
- Thickens the vaginal lining so it stops tearing and burning.
- Brings the vaginal pH back to the acidic range it was at before menopause.
- Restores the good bacteria (lactobacilli) that crowd out bad bugs.
- Makes the lining of the urethra and bladder thicker. Burning and urgency ease up.
- Brings back natural moisture, so sex is less painful.
- Cuts repeat UTIs by about half in women past menopause.
The safety story
From 2003 until 2025, low-dose vaginal estrogen carried the FDA's most serious warning, called a "black-box" warning. The warning listed risks like breast cancer, stroke, and blood clots. Those risks came from studies of systemic hormone therapy: pills and patches that raise estrogen across the whole body. They do not match what happens with the local low-dose vaginal form, which barely reaches the bloodstream at all.
In November 2025, the FDA took the black-box warning off low-dose vaginal estrogen. The change came after twenty years of safety data. Plenty of doctors, pharmacists, and patients still go by the old warning, so you may need to ask for vaginal estrogen by name.
A 2025 study looked at more than one million older women on Medicare. Of those with vaginal or urinary symptoms from menopause, fewer than 1 in 10 ever filled a script for vaginal estrogen. A second 2025 study looked at nearly three million women. About 7 in 10 with these symptoms got no treatment at all.
The forms you can choose from
| Form | Brand examples | Typical use |
|---|---|---|
| Cream | Estrace, generic estradiol | Small amount with an applicator, nightly for 2 weeks, then 2 to 3 times per week long-term |
| Tablet or insert | Vagifem, Yuvafem, Imvexxy | One small tablet placed in the vagina nightly for 2 weeks, then twice per week |
| Ring | Estring | One soft ring you place in the vagina, replaced every 3 months. No daily routine to remember. |
All three work about the same for GSM. Pick the one that fits your life. Cream lets you adjust the dose and is useful if you want to rub a small amount on the vulvar tissue too. Tablets are tidier than cream. The ring is the lowest-effort option once it's in, since you replace it every three months.
Generic estradiol cream lists for about $34 a tube at Cost Plus Drugs (May 2026). One tube lasts 2 to 3 months at maintenance dosing, or roughly $12 to $17 a month. The branded tablet and ring are pricier, but insurance often covers them. If your pharmacy quotes a much higher price, ask about generics or check Cost Plus Drugs or GoodRx.
How long until you feel better
- 2 to 4 weeks: tissue starts to thicken. Many women notice less burning and less dryness.
- 8 to 12 weeks: close to full effect. Painful sex often eases by this point.
- 3 months and beyond: recurrent UTIs taper off. The benefit stays as long as you keep using the treatment.
How long do you stay on it?
For most women, indefinitely. GSM is driven by ongoing low estrogen, so the symptoms come back if you stop. There is no set time limit for low-dose vaginal estrogen.
Common reasons women have been told no
- "Estrogen causes cancer." Local low-dose vaginal estrogen has not been shown to raise the risk of breast or uterine cancer. Ask whether your doctor is thinking of hormone pills, which are a different medicine.
- "You had breast cancer." See Chapter 7. The flat no is no longer the standard for many women.
- "You don't need a progestin to go with it." Correct. Low-dose vaginal estrogen does not require a progestin even if you still have your uterus.
- "Just use a lubricant." Lubricants help with sex. They do not restore the tissue.
The FDA dropped the warning in November 2025, but pharmacy software and printed inserts take time to catch up. You may still see scary text on the box or hear concern from a pharmacist. The local low-dose form acts on vaginal tissue only. Very little reaches your bloodstream. That is why the warning was removed.
Other treatment options compared
Vaginal estrogen is the cornerstone. There are other tools too, and a few of them get marketed harder than the evidence supports.
| Option | How it works | Best for | Bottom line |
|---|---|---|---|
| Vaginal DHEA (prasterone, Intrarosa) | A nightly vaginal insert. The cells in the vagina turn it into small amounts of local estrogen and androgen. | Women who prefer a non-estrogen label, or whose oncology team prefers it. | A good option. Works well. Nightly use and higher cost than generic estrogen cream. |
| Ospemifene (Osphena) | A daily pill that acts like estrogen in vaginal tissue and blocks estrogen in breast tissue. | Women who do not want to use any vaginal product. | An option if you refuse vaginal therapy. Side effects can include hot flashes and a small added risk of blood clots. |
| Vaginal moisturizers | Non-hormone gels or suppositories (Replens, Revaree, hyaluronic acid) used 2 to 3 times per week. | Mild symptoms, or as an add-on to vaginal estrogen. | Helpful for comfort. Do not restore the tissue. Not a replacement for vaginal estrogen in moderate or severe GSM. |
| Lubricants | Used at the time of sex. Water- or silicone-based are best. | Reducing rubbing and soreness during sex. | Useful for everyone with GSM. Avoid products with warming agents, glycerin, or fragrance. |
| Pelvic floor physical therapy | Hands-on therapy and home exercises to relax tight pelvic floor muscles, often with dilators. | Pain with sex that does not improve once tissue heals. | An important partner to vaginal estrogen for many women. Treating only the tissue and not the muscle leaves pain in place. |
| Vaginal laser | An in-office laser treatment marketed for vaginal "rejuvenation." | Marketed widely; evidence does not back the marketing. | Sham-controlled trials show no benefit over placebo. The FDA has warned about marketing claims. Expensive and not a replacement for vaginal estrogen. |
| Systemic hormone therapy (pills, patches) | Estrogen across the whole body, with progestin if you still have a uterus. | Women who also have moderate or severe hot flashes. | Not the right tool for GSM alone. About 1 in 8 women on systemic therapy still need vaginal estrogen added. |
Lubricants vs. moisturizers
A lubricant is for the moment of sex. A moisturizer is used regularly, like a face cream, to hydrate the tissue between sexual activity. Most patients end up using both on top of vaginal estrogen.
Avoid douches and scented products in or near the vagina. They can irritate already fragile tissue.
If you had breast cancer
For decades, women with a history of breast cancer were told a flat no to vaginal estrogen. That advice came from data on hormone pills, which are a different drug entirely. The current standard is case-by-case, and for many patients the answer is now yes once their cancer team weighs in.
Why the old answer was too broad
The fear came from big studies of systemic hormone therapy. Those studies looked at women with no history of breast cancer. They found small bumps in breast cancer risk with whole-body hormone use. Doctors then took that warning and put it on the local, low-dose vaginal form. But almost none of the vaginal form reaches the bloodstream.
What the evidence now shows
- Several large studies tracked women who used low-dose vaginal estrogen. Their breast cancer did not come back more often.
- For women on tamoxifen, a 2022 study from Denmark, and others since, found no added risk.
- The tricky group is women on aromatase inhibitors (anastrozole, letrozole, exemestane). These drugs push estrogen close to zero. Even a small bump from vaginal estrogen could in theory blunt that effect. The data here are mixed. The choice should be made with your oncologist.
Where things stand in 2025
Big cancer and menopause groups now agree on a case-by-case approach:
- If you finished cancer treatment and are off hormone-blocking drugs, or you take tamoxifen, vaginal estrogen can often be an option. Most teams try other steps first. These include moisturizers and lubricants.
- If you are on an aromatase inhibitor, talk first about non-estrogen options. These are moisturizers, lubricants, vaginal DHEA, and ospemifene. If those do not help and GSM is hurting your daily life, low-dose vaginal estrogen may still be on the table with your oncologist's input.
How to bring this up
Oncologists hear this question routinely now. An opener that works: "My GSM symptoms are hurting my quality of life. Could you and my urologist or gynecologist talk about whether low-dose vaginal estrogen is safe for me, even with my history?"
Severe GSM affects sleep, exercise, intimacy, and how you feel about yourself day to day. Treating it is part of your medical care. Your cancer team will weigh the trade-offs with you.
Living well with treated GSM
On treatment, most women notice less dryness and burning within 2 to 4 weeks.
What a good plan includes
The plan is steady use of vaginal estrogen, or one of the non-estrogen options, plus a few small habits that protect the tissue. By 2 to 3 months in, dryness and burning have eased a lot for most women. By 6 months, recurrent UTIs and painful sex have usually settled to a much lower baseline.
Steps you can take on your own
- Use a good lubricant for sex. Water- or silicone-based. Skip products with warming agents, glycerin, parabens, or fragrance.
- Use a vaginal moisturizer 2 to 3 times per week if dryness is part of your picture. Even on vaginal estrogen, this can add comfort.
- Skip things that irritate. Douches, scented soaps, scented wipes, and harsh laundry soap on underwear can all make sore tissue worse.
- Wear breathable underwear and skip long stretches in tight synthetics if you can.
- Keep having comfortable sex if you want to. The tissue does better with use, once treatment has made it less painful.
- Track your symptoms. Note when UTIs hit, when sex was comfortable or not, when dryness flared.
On sex and your partner
Painful sex from GSM is biological and treatable. Many patients stop having sex without telling their partner why. A short talk about what is going on usually changes that. The tissue itself takes 8 to 12 weeks to heal with treatment. If the pelvic floor muscles have learned to guard against pain, that retraining takes longer and usually needs pelvic floor physical therapy.
When to check back in
Plan a follow-up about 3 months after starting treatment to see how you are doing. After that, a yearly check-in is usually enough. Call sooner if you have new bleeding, a new lump, a wound that does not heal, or your symptoms get worse on treatment.
Frequently asked questions
Is this just normal aging?
No. GSM is a named medical condition driven by low estrogen, and it has effective treatment. Without treatment it slowly worsens. With low-dose vaginal estrogen, most women see dryness and burning ease by 2 to 4 weeks and painful sex by 8 to 12 weeks.
Is vaginal estrogen safe?
For most women, yes. The local low-dose form barely reaches your bloodstream. It has not been linked to higher rates of breast cancer, uterine cancer, stroke, or blood clots. The FDA took the black-box warning off in November 2025.
I had breast cancer. Can I use vaginal estrogen?
Often yes, in partnership with your cancer team. Chapter 7 covers this in detail. The flat no that women used to hear is not today's standard for low-dose vaginal estrogen.
Do I have to use vaginal estrogen forever?
If you want the benefit to last, yes. GSM comes from ongoing low estrogen, so the symptoms come back when you stop. There is no set time limit for low-dose vaginal estrogen.
What if I do not want to use estrogen?
You have choices. They include vaginal DHEA (prasterone), the oral pill ospemifene, and steady use of vaginal moisturizers plus lubricants for sex. Chapter 6 has the trade-offs.
Will laser fix this?
The best studies have not shown laser to work better than a fake treatment. The FDA has warned about ad claims. It costs a lot and does not take the place of vaginal estrogen for most women.
Will vaginal estrogen fix the painful sex?
Often yes. The tissue takes 8 to 12 weeks to heal. If pain still happens after that, pelvic floor physical therapy is the usual next step. Muscles that have learned to guard against pain need their own training to relax.
My UTIs keep coming back. Is that GSM?
If you are past menopause, almost always yes. Vaginal estrogen cuts recurrent UTI rates by about half in this group.
Do I need a hormone blood test first?
No. Menopause and GSM are clinical calls. A blood test is not needed to start.
Questions to ask your doctor
Bring this page to your visit.
About the diagnosis
- Do my symptoms fit the picture of GSM?
- Can we do a pelvic exam today to look at the tissue?
- Are there other causes I should rule out, such as a skin condition of the vulva?
About vaginal estrogen
- Am I a candidate for vaginal estrogen? If not, what is the specific reason?
- Are you thinking of vaginal estrogen, or hormone pills? Those are different.
- Which form (cream, tablet, or ring) would you suggest for me, and why?
- How long until I should feel better?
- How long will I need to stay on it?
If you had breast cancer
- Can you talk with my cancer doctor about low-dose vaginal estrogen for me?
- Would vaginal DHEA or ospemifene be a better first step for me?
About other parts of the plan
- Should I see a pelvic floor physical therapist for the pain with sex?
- Could my recurrent UTIs be GSM-related?
- Which lubricants and moisturizers do you suggest?
About the long view
- What should I expect at 3 months on treatment? At 6 months?
- When should we recheck?
- What signs should make me come back sooner?
Words to know
Most of these terms come up in conversations about menopause, GSM, and the medicines used to treat it.
- Genitourinary Syndrome of Menopause (GSM)
- The group of vaginal, vulvar, sexual, and urinary symptoms caused by low estrogen after menopause or other causes of estrogen loss.
- Vulvovaginal atrophy
- The older name for GSM. Still seen in many medical records. Refers to the same condition but undercounts the urinary and sexual parts.
- Perimenopause
- The years leading up to your final period, when hormone levels swing and start to fall. GSM can begin in this phase.
- Vaginal estrogen
- A low-dose estrogen placed in the vagina as a cream, tablet, or ring. Works on local tissue with very little reaching the bloodstream.
- Systemic hormone therapy
- Estrogen (often with progestin) taken as a pill or patch that raises hormone levels across the whole body. A different medicine with different uses and risks from vaginal estrogen.
- Black-box warning
- The strongest FDA warning placed on a medicine. The one that had been on low-dose vaginal estrogen since 2003 was removed in November 2025.
- Dyspareunia
- The medical word for pain with sex.
- Lactobacilli
- The good bacteria that live in a healthy vagina and keep it acidic. They depend on estrogen.
- Vaginal pH
- A measure of how acidic the vagina is. Lower (around 4) is the healthy premenopausal range. Higher (5 to 7) is typical after menopause and is part of what lets bad bugs grow.
- Aromatase inhibitor (AI)
- A breast cancer medicine (anastrozole, letrozole, exemestane) that pushes estrogen levels to nearly zero. Often causes severe GSM.
- Tamoxifen
- A breast cancer medicine that blocks estrogen in breast tissue but acts like estrogen in some other tissues. Can cause GSM-like symptoms.
- Vaginal DHEA (prasterone, Intrarosa)
- A nightly vaginal insert. Vaginal cells turn it into small amounts of local estrogen and androgen. An alternative to vaginal estrogen.
- Ospemifene (Osphena)
- A daily pill that acts like estrogen in vaginal tissue. An option for women who do not want any vaginal product.
- Pelvic floor physical therapy
- Hands-on therapy and home exercises that help relax tight pelvic floor muscles. Often paired with vaginal estrogen when pain with sex does not fully resolve.
- Recurrent UTI
- Two or more proven urinary tract infections in 6 months, or three or more in 12 months. In women past menopause, often part of GSM.
Sources and further reading
This guide is built from the latest menopause, urology, and cancer-care guidelines.
- The Menopause Society. 2025 Position Statement on Genitourinary Syndrome of Menopause. menopause.org
- FDA. Removes Black Box Warning on Low-Dose Vaginal Estrogen (November 2025). fda.gov
- Portman DJ, Gass ML; ISSWSH and NAMS Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy. Menopause, 2014. pubmed.ncbi.nlm.nih.gov
- Raz R, Stamm WE. A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract Infections. NEJM, 1993. pubmed.ncbi.nlm.nih.gov
- ACOG. Committee Opinion: The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer. acog.org
- Cold S, et al. Vaginal estrogens and risk of breast cancer recurrence: a Danish nationwide cohort study. JNCI, 2022. pubmed.ncbi.nlm.nih.gov
- Li FG, et al. Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial. JAMA, 2021. jamanetwork.com
- FDA Safety Communication. FDA Warns Against Use of Energy-Based Devices to Perform Vaginal "Rejuvenation" (2018, reiterated). fda.gov
- Gallo K, Zhang CA, Burton C, Kamdar N, Enemchukwu EA. Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause. JAMA Network Open, 2025;8(12):e2549822. jamanetwork.com
- Ghosh A, D'Amico MJ, Shah YB, et al. Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis. Canadian Journal of Urology, 2025;32(6):627-632. jdc.jefferson.edu
- Labrie F, et al. Intravaginal prasterone (DHEA) for the treatment of vulvovaginal atrophy. Menopause, 2016. pubmed.ncbi.nlm.nih.gov
- The Menopause Society. MenoNote: Genitourinary Syndrome of Menopause patient handout. menopause.org
- Cost Plus Drugs. Estradiol 0.01% vaginal cream listing, accessed May 2026. costplusdrugs.com
About this guide. Written by the WellPrept Clinical Team. Reviewed by board-certified urologists and gynecologists. Designed to be read alongside your doctor's instructions, not as a replacement for them.